Corrigendum to "OVATION-2: A randomized phase I/II study evaluating the safety and efficacy of IMNN-001 (IL-12 gene therapy) with neo/adjuvant chemotherapy in patients newly-diagnosed with advanced epithelial ovarian cancer" [Gynecol Oncol 2025 Jun 197 182-191]

Gynecol Oncol. 2025 Dec:203:182-183. doi: 10.1016/j.ygyno.2025.10.031. Epub 2025 Nov 6.
No abstract available

Publication types

  • Published Erratum